Trinity Biotech | TRIB - Net Income


Trinity Biotech reported $-5.14M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Bayer EUR -963M 764M Sep/2025
Bio-Rad Laboratories USD 317.8M 253.8M Jun/2025
EDAP TMS EUR -5.6M 1.47M Jun/2025
J&J USD 5.12B 36M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Siemens EUR 1.62B 427M Sep/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
Tosoh JPY 17.25B 16.4B Dec/2025
Trinity Biotech USD -5.14M 11.82M Sep/2025
Veracyte USD 19.14M 20.12M Sep/2025